Literature DB >> 17599308

Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin.

Yves Gillet1, Philippe Vanhems, Gerard Lina, Michele Bes, Francois Vandenesch, Daniel Floret, Jerome Etienne.   

Abstract

BACKGROUND: Necrotizing pneumonia due to Panton-Valentine leukocidin-producing strains of Staphylococcus aureus is associated with a high mortality rate. We sought factors associated with vital outcome in 50 cases occurring from 1986 through 2005.
METHODS: We compared the clinical and biological characteristics of 50 patients according to their vital outcome and examined the characteristics of the corresponding S. aureus isolates.
RESULTS: The overall mortality rate was 56%, and the median survival time was 10 days. All of the deaths were attributed to S. aureus infection and were secondary to refractory shock and/or respiratory failure. Fatal outcome was associated with classical severity factors, such as the need for mechanical ventilation or inotrope support, and with onset of the acute respiratory distress syndrome. Airway bleeding was strongly associated with fatal outcome (P=.002). Patients who had focal staphylococcal infection before the onset of pneumonia had a significantly lower mortality rate (P=.002). The main biological feature associated with death was leukopenia (P<.001). In multivariate analysis, leukopenia and erythroderma occurring within the first 24 h after admission to the hospital were independently associated with fatal outcome. Erythroderma was not associated with toxic shock syndrome toxin.
CONCLUSIONS: Airway bleeding, erythroderma, and leukopenia are associated with fatal outcome from Panton-Valentine leukocidin-positive S. aureus necrotizing pneumonia. More work is needed to develop more efficacious therapy against this highly lethal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599308     DOI: 10.1086/519263

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  83 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

3.  Rapidly fatal necrotizing pneumonia in a 12-year-old boy caused by co-infection with parainfluenza virus type 1 and Panton-Valentine leukocidin (PVL)-positive methicillin-sensitive Staphylococcus aureus.

Authors:  J J Wenzel; J Hentschel; W Silvis; W Permanetter; J Mattes; B Kochanowski; R Herterich; W Jilg; H J Linde
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

Review 4.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  Panton-Valentine leukocidin-positive staphylococcus aureus necrotising pneumonia complicating pandemic A(H1N1) influenza infection.

Authors:  Florent Valour; Jean-Christophe Richard; Christian Chidiac; Tristan Ferry
Journal:  BMJ Case Rep       Date:  2013-08-23

6.  Methicillin-resistant Staphylococcus aureus: from the hospital to the community.

Authors:  Armando Paez; Daniel Skiest
Journal:  Curr Infect Dis Rep       Date:  2008-03       Impact factor: 3.725

7.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

8.  Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes.

Authors:  Nicolas Rouzic; Frédéric Janvier; Nicolas Libert; Etienne Javouhey; Gerard Lina; Jacques-Yves Nizou; Pierre Pasquier; Didier Stamm; Louis Brinquin; Christophe Pelletier; François Vandenesch; Daniel Floret; Jerome Etienne; Yves Gillet
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

9.  Successful management of Panton-Valentine leukocidine-positive necrotising pneumonia and A/H1N12009 influenzavirus coinfection in adult.

Authors:  Karena Riedweg-Moreno; Frederic Wallet; Caroline Blazejewski; Anne Goffard
Journal:  BMJ Case Rep       Date:  2014-01-16

10.  Staphylococcus aureus beta-toxin induces lung injury through syndecan-1.

Authors:  Atsuko Hayashida; Allison H Bartlett; Timothy J Foster; Pyong Woo Park
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.